I think for the last 12 months momentum has been against biotech...

I think for the last 12 months momentum has been against biotech / pharmaceutical investing but it looks like the worm has finally turned and I think momentum has finally turned to the positive and we should see the share price significantly higher in the next 6 months for the following reasons .
1.Takeovers are starting to increase .
2. Tax loss selling has finished .
3.Shorters re still about 7.4 mill short (I think they have started to buy back over the last couple of days)
4.New indications will happen over the next couple of months with the first one next week I reckon.
5.I am hearing from my sources that DAYBUE is tracking well and Acadia seem to be becoming more bullish going forward .
6.I find it very interesting that Acadia paid a fortune for NNZ2591 for retts syndrome and fragile X but was not mentioned in their recent R&D day maybe they don’t want to increase the NEU share price .
7. Cash at bank approx $340 million .
8.Franking credits of $80 mill plus .
9.The company has the ability to recommence the buyback and if they do that that will certainly put the squeeze on the shorters .
10. Company has been recently been over in Boston recently at the biotech/pharmaceutical investment conference (a little conference with over 48,000 participants and would be confident that the company would be entertaining a lot of interest in their platform .